DrugPatentWatch Database Preview
Drugs in MeSH Category Cytochrome P-450 CYP2C19 Inducers
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn | RIFAMPIN | rifampin | CAPSULE;ORAL | 065028-001 | Mar 14, 2001 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Sanofi Aventis Us | RIFADIN | rifampin | CAPSULE;ORAL | 050420-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||
| Mylan Labs Ltd | RIFAMPIN | rifampin | INJECTABLE;INJECTION | 065421-001 | May 22, 2008 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
